Clinical Vignette: A 64-year-old female with essential tremor (ET) presents for evaluation of deep brain stimulation (DBS) candidacy. Examination revealed subtle dystonic features as well as a disabling postural-action tremor.
Second, does the presence of dystonic features alter DBS target selection from the conventional ventralis intermedius (Vim) target in ET?

Clinical solution
Each member of the Yale DBS interdisciplinary team (comprising a movement disorders neurologist, a functional neurosurgeon, and a neuropsychologist) examined and discussed the patient. A unilateral right Vim target was selected to address the more severe left-hand postural and action tremor, despite the presence of mild dystonic hand posturing. The interdisciplinary team might have selected a different surgical target had the dystonia been more severe or more generalized. The globus pallidus internus (GPi) could be used as a future rescue target if Vim stimulation was unable to provide sufficient benefit to dystonia. Tremor and dystonic posturing in the left arm both improved with unilateral Vim DBS (Video 2, Figure 1) . A second rescue DBS lead was not needed.
Gaps in knowledge
The first issue raised by this case is the challenge of properly diagnosing tremor syndromes. The overlap between ET and dystonic tremor (DT) has spawned confusion even for experienced movement disorder physicians. Historically, ET has likely been overdiagnosed while dystonia syndromes with prominent tremor may be underrecognized. 1 The Task Force on Tremor for the International Parkinson and Movement Disorder Society created a new consensus statement on the classification of tremors in 2017. The new classification scheme emphasized ET as an isolated tremor syndrome of bilateral upper limb action tremor, of at least 3 years' duration with or without tremor in other locations, and in the absence of other neurological signs (dystonia, ataxia, or parkinsonism). 2 The tremor in ET is also typically characterized as a 4-12 Hz postural-action tremor affecting the limbs in a slightly asymmetric fashion. 3 The head and voice are affected less commonly and usually noticed after limb involvement. 4 However, there was insufficient evidence to support the inclusion of ''onset of tremor in the upper limbs'' as part of the new diagnostic classification for ET. The case presented satisfies much of these criteria, and a prolonged history of progressive tremor with a family history of ET would favor an underlying diagnosis of ET. The presence of a single tremor axis on the patient's spiral drawing may further support an ET diagnosis. 5 In contrast to ET, the diagnosis of DT rests on the idea that the tremor does not occur in isolation and recognizes that tremor can be a basic element of a dystonic contraction. The tremor of DT is most commonly an action tremor that affects the head, upper limbs, and voice, and is commonly induced by specific postures and actions or in a task-specific form. A geste antagoniste (sensory input) or alternatively a posture (null point) that reduces or eliminates the tremor is characteristic of DT and can help distinguish it from ET. 6 When the features of ET and DT overlap, diagnostic uncertainty may exist. There is no consensus on what additional signs (e.g., impaired tandem gait, dystonic posturing, mild cognitive impairment) are acceptable within the definition of ET. ''ET plus'' is the new diagnostic criteria proposed to classify a tremor with the characteristics of ET in the presence of additional mild examination findings of uncertain significance. This entity has been further distinguished from ''tremor associated with dystonia,'' in which tremor is present in a body part separate from the region with dystonia. 2 These distinctions between tremor syndromes are reliant on a clinician's subjective assessment of the significance of a patient's non-tremor-related examination features. There is also no consensus on the severity of additional signs necessary to classify a patient with DT rather than ET plus. Although the dystonic features in this case were very mild, a similar case with more prominent dystonia might be classified as DT rather than ''ET plus.'' The classification is highly dependent on the interpretation of the clinician. Some clinicians may even label this phenotype as a mixed tremor syndrome. The lack of diagnostic consensus and the variability of diagnostic schema in the literature contribute to a second clinical dilemma: What evidence is available to guide the choice of DBS target selection when treating tremor with associated dystonic features? The DBS target of choice for medically refractory postural-action tremor has traditionally been the Vim. There is robust evidence for its effectiveness in treating ET and postural-action tremor in general. 7, 8 Stimulation of the thalamic ventralis oralis anterior and posterior (Voa/Vop), as a pallidal receiving area, has also been utilized in the treatment of postural-action tremors alone or as a rescue lead for refractory tremor. 9 There is equally convincing evidence supporting
GPi stimulation for the treatment of dystonia. 10, 11 Even the subthalamic nucleus (STN) has been occasionally reported as a possible target for the treatment of dystonia. 12 However, available evidence regarding DBS treatment for DT specifically has been limited to smaller retrospective reviews which often mix patients with variable forms of dystonia and tremor. These studies are naturally biased to include patients with more severe dystonia than our current case; however, they offer some of the only available insight into the variable effects of DBS target selection on the dystonic features associated with tremor ( Table 1) .
Studies of tremor patients treated with Vim or GPi DBS may offer the broadest available evidence to guide target selection in cases with both tremor and dystonia. Vercueil et al. 13 examined one of the largest series of patients with tremor (n 5 19) in the setting of both primary and secondary dystonia. Twelve patients treated with Vim stimulation had no improvement in dystonia, and three of these patients underwent subsequent GPi DBS to address residual dystonia. However, six out of nine patients identified as having a ''DT phenotype'' achieved tremor suppression with Vim DBS (whether alone or in conjunction with GPi DBS). 13 Hedera et al. 14 reported a similar variable benefit for tremor and dystonia, which appeared to be highly dependent on target selection. These authors examined 10 patients with DT. Subjects with Vim DBS achieved the greatest tremor control (average improvement of the Washington Heights-Inwood Genetic Study of Essential Tremor Scale score was 84.7%). GPi DBS resulted in less improvement in the average tremor score (39.8%). GPi stimulation was, however, effective in treating severe dystonia, and subjects with Vim DBS required additional medical treatment for residual dystonic symptoms. 14 Morishita et al. 15 analyzed three cases of DT and found similar results. Of particular note was a case of bilateral GPi DBS that resulted in improvement in dystonic gait but persistent head and upper extremity tremor. This case required subsequent bilateral Vim DBS therapy, with improvement in the Fahn-Tolosa-Marin Tremor Rating Scale (FTM-TRS) from 40 to 22. 15 Vim and GPi DBS were effective in improving tremor and dystonia when both were utilized in combination in this single patient. Neither target alone was sufficient to control both sets of symptoms. Although these case series collectively suggest a variable effectiveness for dystonia and tremor targets, there are isolated reports of adequate improvement in both symptoms via stimulation of a single target. Ramirez et al. 16 analyzed GPi DBS outcomes in two patients with focal limb DT in the absence of generalized dystonia. Treatment with GPi DBS led to an 82% and 79% improvement of the FTM-TRS in each case. In both cases, focal DT was significantly improved with GPi DBS and did not require additional thalamic stimulation to address the tremor. 16 Evidence for the singular effectiveness of targets other than Vim or GPi has been more limited. Chou et al. 17 reported a case of a 52-yearold female with cervical dystonia and subsequent head and arm tremor treated with STN DBS. The patient's course suggested the modern classification of ''tremor associated with dystonia.'' Bilateral STN DBS led to an improvement in her Toronto Western Spasmodic Torticollis Rating Scale from 14 to 3, with ''full suppression'' of her head and hand tremors. 17 While additional case reports of STN improvement in DT have been lacking, the posterior subthalamic area (PSA) may also be a reasonable target for DT. The PSA comprises the caudal zona incerta (cZi), including the pallidothalamic white matter and prelemniscal radiation. Stimulation in this region has been reported to be effective in reducing several tremor syndromes across multiple etiologies. 18 With regards to DT specifically, a few case reports have shown significant improvement in both tremor and dystonia from cZi stimulation. [19] [20] [21] The varied surgical approaches and assessment techniques in these cases complicate interpretation of the results, making definitive conclusions regarding PSA targeting for DT difficult. Ultimately, the promise of a single target to reliably improve both tremor and dystonia in an individual case remains unclear and may be unrealistic, given the differences in phenomenology and pathogenesis in these varied case reports.
In conclusion, there are likely multiple DBS targets that may be effective in improving DT. The current limited evidence suggests that Vim DBS is likely the most effective target for reducing tremor, while GPi DBS is more likely to improve dystonia. However, isolated cases reports suggest this may not be an absolute rule. The severity of the relative components of tremor and dystonia and their contributions to patient disability should contribute to expert target selection. However, when these components impact disability equally, the optimal target(s) remains debatable. Adherence to a more standardized tremor diagnostic classification may or may not help in target selection. Much of the cited literature relies on clinometric scales of tremor or dystonia as their primary measure, without detailed description of the tremor phenotype. As new diagnostic criteria are implemented, new scales must be adopted to reflect the areas in which tremor and dystonia overlap so that objective measures of DBS response can be tracked. The use of advanced DBS technology (e.g., directional current steering, closed loop systems) and surgical techniques (e.g., fiberbased targeting) may aid in identifying optimal targets and programming strategies for tremor phenotypes that do not rely on subjective criteria.
Expert commentary
This case highlights the limited information available to guide the clinician in the choice of DBS target(s) for individual patients with ET and dystonic features regardless of the tremor classification system. ET can be observed either in isolation or can be associated with other neurologic symptoms such as dystonia (''ET plus''). The distinction between ''ET plus'' and DT relies on the evaluation of the examiner and thus is subjective. The FDA-approved DBS target for ET is the Vim and for dystonia it is usually the GPi. This current paper summarizes the available literature investigating the use of different DBS targets for management of both ''ET plus'' and DT. The classification of tremors into ET, ''ET plus,'' and DT has been a recent development in the field and has not yet been widely embraced (2017). Additionally, any best target conclusions based on the published literature should be interpreted cautiously. Vim, GPi, STN, and cZi have all been utilized as targets for tremor with associated features of dystonia and all have had varying degrees of success. Additionally, there is an unpublished experience in Voa/ Vop thalamus. In our experience, Vim has been the initial target of choice when the tremor is postural-action and the tremor is the disabling feature of the presentation. In the current case, the dystonic features were mild and the choice for Vim over GPi was clear. Since there are so few ''ET plus'' and dystonia tremor cases implanted per year (even in expert centers) it will be important for groups to aggressively publish the results of cases and case series, preferably using the newly developed and standardized classification into ET, ''ET plus,'' and DT.
